About Annoroad

    

1550110233491415.jpg  1550110280236847.jpg


Annoroad Gene Technology was founded in 2012 and is headquartered in Beijing with a South Center in Yiwu, Zhejiang Province. It is a well-known enterprise in Chinese genomic industry, a leading NIPT service provider in China, and a top-ranking medical genome center in Asia, focusing on the industrial application of next generation genomic technology in human health and medicine, and life science research.


Since the establishment of the company, Annoroad has got the following honorary titles: National High-tech Enterprise, the first High-throughput Sequencing Clinical Application Pilot Organizations of NHFPC (National Health and Family Planning Commission), NDRC (National Development and Reform Commission) first Genetic Test Technology Application Demonstration Center, Beijing Municipal Commission of Development and Reform Precision Medical and Genetic Engineering Beijing Engineering Laboratory, Zhongguancun High-tech Enterprises, the first Beijing Biomedical Industry Leap-forward Development Project (G20 Project) during the 13th Five-Year Plan period, Beijing Science and Technology R&D Institution, Beijing Patent Pilot organization, Beijing Intellectual Property Demonstration Organization, Beijing Enterprise Technology Center. The company has a post-doctoral scientific research station and was selected as one of the top 20 in Deloitte-Yizhuang high-tech growth, the top 30 in China's most technologically advanced companies, and the top 50 in China's most investment-worthy companies. In the field of medical health, Annoroad has launched a lot of excellent high-throughput sequencing medical test and research projects in the fields of reproduction, cancer diagnosis and treatment, gene health and other fields, including Non-Invasive Prenatal Test/NIPT, Chromosomal abnormality test, ctDNA test, gene test of blood disease, breast cancer, and ovarian cancer, and so on.


In the field of scientific and technological services, as a sub-brand of Annoroad, Anno Gene has carried out extensive scientific research cooperation with domestic and foreign universities, research and development institutions in the multi-group level of genomics, transcriptomics and epigenetics. The fields involved include basic research on major diseases of human beings, molecular breeding of plants and animals, genetics and evolution, etc., and it has formed distinctive advantages in analysis of gene expression, single-cell multi-omics, chromosome Hi-C, etc., so as to provide excellent technical solutions for life science research. Among them, single-cell sequencing technology, as the core research and development technology in the field of scientific research services, was named the first "Zhongguancun Frontier Technology" in 2019.


Based on the domestic and foreign core talent team, Annoroad has its own self-developed advanced genome sequencing and bioinformatics technology, and has established an advanced high-throughput sequencing platform and high-performance computing platform. It has also achieved strategic cooperation with companies such as Illumina, Alibaba Cloud, PacBio and launched the leading desktop high-throughput sequencer NextSeq 550AR and the Biological Big Data Platform "Solargenomics". Annoroad has established excellent product systems and brand effects in sequencing equipment, molecular diagnostic reagents, medical test and research, scientific research services, gene big data and cloud platform services, forming a whole industrial chain layout covering the upstream, midstream and downstream of the business and a strong bio-IT industrial service capacity. In the future, Annoroad will adhere to the philosophy of "improving the quality of life with science and innovation" and strive to build itself into an excellent enterprise in the medical and health field integrating "big science, big manufacturing, big health, big service, big data and big resources".


About the South Center of Annoroad

 

1564634513428315.jpg  1564634522965839.jpg


Zhejiang Annoroad Biotechnology Co., Ltd. was officially completed in July 2018. As the South Center of Annoroad, it will rely on the headquarters of Beijing Annoroad, which has the core advantages of genetic sequencing industry chain in the upstream, midstream and downstream resource. The South Center of Annoroad will create four core functional genetic technology ecosystems to be a new business card of Yiwu, including the medical test center, the genetic research institute, the instrumental reagent manufacturing center, and the genetic health center. Together with the headquarters, Annoroad’s philosophy is to enhance the quality of technology and innovation, and the mission is to enable effective and affordable healthcare solutions for all, with an excellent enterprise in the fields of medical and big health.


The medical test center will be one of China's core test bases testin the field of reproductive health and cancer test, and the largest laboratory for sample processing in East China. The genetic research institute will have a world-class research team. It will form the world's leading sequencing center and large data processing supercomputing center. It will be the world's only 3D genomics research center, and the world’s leading single-cell multi-omics research center. The genetic health center will become the most comprehensive genetic health industry base in the national test technology and production platforms. In the future, it will reach 150,000 samples to improve residents' health management and disease prevention. In addition, the genetic health center and local medical regulatory authorities will promote the application and industrialization of standardized genetic testing.test The instrumental reagent manufacturing center will form an upstream industrial chain, and become a demonstration base for instrument and reagent manufacturing and operation management.


With its unique location advantages, the South Center of Annoroad will cooperate with Nanjing Annoroad and Guangzhou Annoroad subsidiaries, together with the North Center-Beijing Annoroad to form the "Two Centers in One South and One North" nationwide. They work together to build a leading ecological enterprise in the genome industry, and adhere to the philosophy of "improving the quality of life with science and innovation" to build a whole industry chain layout from the upstream manufacturing of instruments and reagent, midstream big data services to downstream medical, health and technology service applications.


Copyright © Annoroad Gene Technology 京ICP备12029022号-1